Total Funding
59
66
Total FundingSeed raised
Growth Score 59 in past quarter
-29 pts
Heat Score 66 in past quarter
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
73224
Aecor Bio focus on development and discovery of peptides.

Hofseth BioCare
About the Company
Aecor.bio is a company focused on developing novel peptide therapies to overcome treatment resistance, a major challenge in many diseases. They use AI-driven methods to design and synthesize peptides targeting disrupted gene expression responsible for treatment resistance at the cellular level. Their approach includes synthesizing thousands of
unique peptides with proprietary algorithms, identifying gene expression changes linked to resistance, and repairing cellular micro-environments to reverse these changes.